Glasgow hospital puts a dedicated paediatric surgical robot into routine use
The Royal Hospital for Children in Glasgow has become the first hospital in the world to own a surgical robot dedicated solely to children. The Versius Plus system is now set to support paediatric operations across a range of specialties after a £1.5m donation from the Coldstones Charitable Trust to Hi Scotland, the innovation arm of the Glasgow Children’s Hospital Charity.
The move matters because children are not simply smaller adults on the operating table. Their anatomy is smaller, their margins for error are tighter, and the clinical priority is not just completing an operation safely but doing so with the least possible tissue disruption. In that setting, robotic-assisted keyhole surgery offers a different kind of precision: steadier instrument control, improved access in confined spaces, and the potential to reduce the trauma that often follows larger incisions.
Michael Jacovides, consultant paediatric surgeon and clinical lead for the robotic surgery programme, described robotic-assisted surgery as something that will increasingly become part of children’s care. Glasgow’s team is already treating the technology as more than a novelty. It is being built into a service that will expand to more conditions and, eventually, to more children and babies across Scotland.
More reach through keyhole surgery in smaller bodies
The robot is intended to improve access during minimally invasive procedures. In practical terms, that means surgeons can work through smaller entry points while maintaining control over instruments inside the body. For paediatric cancer, urology, abdominal, thoracic and gastrointestinal surgery, that kind of reach can be especially valuable when anatomy is tight, delicate or already altered by disease.
A brief sentence captures the clinical logic: smaller incisions can mean smaller consequences.
Doctors at the hospital said the robot can provide enhanced precision while reducing pain, minimising scarring and helping patients return to everyday life more quickly. Those goals align with the broader direction of modern paediatric surgery, where the aim is not only survival or disease control, but also a cleaner recovery with less disruption to growth, mobility and family life.
The first child in the UK to undergo surgery using Versius had the procedure in 2024, after several adult operations had already been completed with the system. Glasgow’s programme, however, goes further than adoption. The hospital is believed to be the first dedicated children’s hospital in the world to purchase and own the platform exclusively for paediatric patients.
That distinction is operationally important. Shared robotic systems often sit inside large adult hospitals, where paediatric access depends on scheduling, staffing and institutional priorities. Owning a dedicated platform inside a children’s hospital creates a different model: the technology can be shaped around child-sized instruments, paediatric workflows and a surgical culture built from the start around younger patients.
More than 30 evaluation procedures paved the way
Before the programme moved into routine use, surgeons carried out more than 30 procedures with the robot during an evaluation phase. That kind of run-in matters because robotic surgery is only as useful as the team’s ability to deploy it smoothly. The hardware may be advanced, but the real test sits in operating theatre discipline, coordination between console and bedside teams, and the selection of cases where the technique adds value rather than complexity.
The evaluation phase also suggests a deliberate rollout rather than an abrupt handover to new technology. In paediatric surgery, that caution is essential. Operative time, positioning, instrument exchange and access to key structures can all become more difficult when working in a small patient. A programme that starts with evaluation cases is more likely to build durable expertise than one that leans on publicity alone.
Kirsten Watson, chief executive of Glasgow Children’s Hospital Charity, called the donation extraordinary and said it was enabling something genuinely pioneering for children’s healthcare. The charity’s language reflects the scale of the investment, but the clinical significance lies elsewhere: funding has now turned access to advanced robotic surgery from an aspiration into a working service for children in Glasgow.
A paediatric programme built around precision, not spectacle
Robotic surgery often attracts attention because of the machine itself: articulated arms, a remote console and a theatre that looks unlike conventional surgery. In paediatrics, the more meaningful question is whether the device changes outcomes that matter at the bedside. Reduced pain, less visible scarring and quicker recovery are the outcomes most directly tied to family experience, and they are also the ones surgeons most commonly seek when moving a child from open surgery to a minimally invasive approach.
The likely biological rationale is straightforward. Smaller incisions and more controlled dissection can reduce soft tissue injury, local inflammation and postoperative discomfort. Less tissue disruption may also support faster mobilization and shorter interruption to normal activity, which has obvious value in children who need to return to school, play and feeding patterns as soon as possible.
Jacovides said the service is being developed to cover more conditions and to reach more children and babies across Scotland. He also framed the programme as part of a wider national and international effort to make these technologies more widely used. The message from Glasgow is clear: robotic surgery is moving from experimental visibility toward a more established place in paediatric operative care.
A second sentence is enough here: the theatre technology has already crossed the threshold from trial use to service delivery.
What this means for children’s surgery in Scotland
The Glasgow programme is likely to influence more than one hospital list. If the platform expands as planned, surgeons may be able to offer robotic-assisted procedures across a broader set of paediatric conditions, while training teams in a hospital environment designed for children rather than adapted for them.
For families, the development signals a shift in what a children’s hospital can offer without transferring care into adult surgical settings. For clinicians, it creates a framework for defining which cases are best suited to robotic assistance, which remain better handled with conventional laparoscopy, and how much benefit the technology delivers across different ages and disease categories.
The article does not provide comparative outcome data, complication rates or long-term follow-up, and those details will matter if the programme is to be judged on more than novelty. The immediate evidence is narrower: a dedicated paediatric robot is now in place, more than 30 evaluation procedures have already been completed, and Glasgow has positioned itself as the first children’s hospital in the world to own such a system exclusively for paediatric patients. The next clinical question is not whether the robot exists, but how often it changes surgery in ways that children and families can actually feel.